SEC 8-K and 6-K filings classified by Claude with reasoning, plus Form 4 insider transactions. Ingested from EDGAR’s filing stream in near-real time, reconciled overnight.
Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
Inflection Point Acquisition Corp. III entered into Amendment No. 2 to its Business Combination Agreement with Air Water Ventures Holdings Limited, materially reducing aggregate base consideration from $300M to $200M, restructuring earnout triggering events, and reducing maximum earnout shares from 30M to 20M.
View raw filing on EDGAR →The filing discloses an unregistered sale of 2,701,420 shares of common stock by certain stockholders acquired in connection with Ondas Inc.'s acquisition of Omnisys Ltd. The shares are being registered for resale via a prospectus supplement to an S-3ASR registration statement. This represents a dilutive equity issuance material to investors assessing ownership and capital structure, particularly given the acquisition context and the substantial share count involved.
View raw filing on EDGAR →The filing discloses entry into a Business Combination Agreement dated May 25, 2026, between Axiom Intelligence Acquisition Corp 1 (SPAC) and Terra Quantum AG, representing a material acquisition/merger transaction. The disclosure details the parties, agreement structure, and contemplated shareholder vote, which are hallmarks of M&A activity under Item 1.01 or 2.01. This is a transformative event for the SPAC and would materially affect investor assessment of the registrant.
View raw filing on EDGAR →The disclosure announces a mandatory separation of the Company's units into separately traded Class A Ordinary Shares (ticker "APUR") and Rights (ticker "APURR") effective June 10, 2026. While this is a structural capital markets event affecting how the Company's securities trade, it does not fit neatly into the more specific event categories (not an M&A activity, not a dilutive issuance, not a delisting). The event is material to investors as it changes the trading mechanics and liquidity profile of the Company's securities, warranting disclosure under Item 8.01 as an "Other Event."
View raw filing on EDGAR →This Item 8.01 disclosure centers on a Forward Purchase Agreement entered into on June 1, 2026, in connection with Live Oak Acquisition Corp. V's proposed initial business combination with Teamshares Inc. The filing discloses the trust account redemption price ($10.55 per share as of June 8, 2026) and references the underlying Merger Agreement dated November 14, 2025 (as amended). While the Item 8.01 framing emphasizes the trust disclosure requirement, the substantive event is the material acquisition/business combination activity—the forward purchase transaction is a financing mechanism directly tied to the proposed merger. This is a core M&A event material to investors assessing the registrant's strategic direction and capital structure.
View raw filing on EDGAR →Jasper Therapeutics received written notice from Nasdaq on June 3, 2026, that its voting common stock bid price closed below the $1.00 minimum requirement for 30 consecutive business days under Nasdaq Listing Rule 5550(a)(2). The company has been granted an initial 180-day compliance period (until November 30, 2026) to regain compliance, with potential for a second 180-day period if certain conditions are met. This is a classic delisting risk disclosure under Item 3.01, materially affecting investor assessment of the company's continued public trading status.
View raw filing on EDGAR →This Item 5.07 discloses the results of an annual stockholder meeting covering three proposals: election of three directors (Charles Biederman, Patrick J. Callan Jr., and Jeffrey A. Gould), a non-binding advisory vote on executive compensation for 2025, and ratification of Ernst & Young LLP as independent auditors for 2026. The detailed voting tallies (For, Against, Abstain, Broker Non-Votes) for each proposal are the core disclosure required by Item 5.07, making this a textbook shareholder vote results event.
View raw filing on EDGAR →Rain Enhancement Technologies issued 10,283,984 shares of Class A Common Stock unregistered, including a $4,000,000 debt-to-equity conversion from RHY Management LLC (affiliated with Chairman Harry You) and grants to officers, directors, advisors, and consultants, relying on Section 4(a)(2) and Regulation D exemptions. This represents material dilution to existing shareholders and a significant capital structure change.
View raw filing on EDGAR →Rain Enhancement Technologies issued 50,000 shares of Class A Common Stock to interim CFO Oanh Truong as compensation for services pursuant to the 2024 Equity Incentive Plan.
View raw filing on EDGAR →Rain Enhancement Technologies issued 490,000 shares of Class A Common Stock as deferred compensation to six directors (Dickerson, Steele, Reardon, Peperzak, Riley, Sylvester), a Senior Technology Advisor (Morris), and an independent contractor (Monroe) pursuant to the 2024 Equity Incentive Plan and previously-disclosed Director Agreements.
View raw filing on EDGAR →The filing discloses a mandatory unit separation effective June 11, 2026, whereby the Company's units will cease trading and the underlying ordinary shares and rights will commence separate trading on Nasdaq under new ticker symbols "BREZ" and "BREZR." This is a material corporate action affecting the trading structure and liquidity of the Company's securities, but does not fit neatly into the more specific event categories (it is not M&A, an executive change, a restatement, or other enumerated events). The mandatory nature and automatic separation make this a material structural change warranting disclosure.
View raw filing on EDGAR →Mr. Matan Fattal resigned as a director and member of multiple committees effective June 5, 2026. While the resignation itself was not disputed, the departure triggered material consequences: the Company lost compliance with Nasdaq Listing Rule 5605(c)(2)(A) (minimum three-member audit committee) and 5605(b) (majority independent board requirement), creating delisting risk that a reasonable investor would find material to their investment decision.
View raw filing on EDGAR →MoonLake Immunotherapeutics held an Annual Meeting of shareholders at which four proposals were voted on and approved: election of Class I director Spike Loy, ratification of Baker Tilly US, LLP as independent auditor, advisory vote on executive compensation, and approval of an amendment and restatement of the 2022 Equity Incentive Plan increasing available shares by 5,000,000 and extending the plan term to 2036.
View raw filing on EDGAR →The Company received notification from Nasdaq that it failed to meet the Minimum Public Holders Rule (Listing Rule 5550(a)(3)) and has been granted an extension through October 3, 2026 to regain compliance. This is a classic delisting risk disclosure under Item 3.01, indicating the Company is at risk of losing its Nasdaq listing if it cannot cure the deficiency within the extension period.
View raw filing on EDGAR →Aditxt entered into a Note Purchase Agreement on June 3, 2026, issuing senior secured convertible notes with an aggregate principal amount of approximately $725,000 in cash proceeds plus consolidation of existing notes totaling $4.4+ million to accredited investors under Section 4(a)(2) and Regulation D Rule 506(b). The unregistered private placement of convertible securities is material to investors due to ownership dilution and capital structure effects.
View raw filing on EDGAR →Big Digital Energy amended and terminated its Rights Agreement (poison pill) effective June 8, 2026, with the Board determining that an active Rights Agreement is no longer needed. This material corporate governance action, disclosed via press release and charter amendment, signals a strategic shift in the Company's takeover defenses and capital structure posture.
View raw filing on EDGAR →The Company's previously announced AI/HPC colocation services agreement with BE Global Development Limited (executed August 9, 2024) has failed to advance to deployment, with key objectives unmet and no revenue received or expected, rendering the project inactive. This material business development failure affects investor assessment of the Company's growth prospects and pipeline.
View raw filing on EDGAR →BRC Group Holdings disclosed unregistered sales of equity securities under Item 3.02 that exceeded 5% of outstanding shares. The Company issued 2,060,683 shares of Common Stock in two private exchanges (May 14 and June 4, 2026) in exchange for cancellation of senior notes, representing approximately 5.1% of the 40.2 million shares outstanding as of June 4, 2026. This is a classic dilutive issuance under Section 3(a)(9) of the Securities Act, material to investors assessing ownership dilution and the Company's capital structure.
View raw filing on EDGAR →Live Oak Acquisition Corp. V has entered into Non-Redemption Agreements with shareholders and its Sponsor in connection with its proposed business combination with Teamshares Inc., a transaction previously disclosed under a Merger Agreement dated November 14, 2025. The Non-Redemption Agreements are material ancillary agreements to the business combination, designed to reduce public share redemptions at the June 16, 2026 shareholder meeting. This disclosure under Item 1.01 reflects a definitive agreement directly supporting the consummation of the proposed business combination.
View raw filing on EDGAR →The filing discloses unregistered issuance of 10,670,000 shares of common stock to five independent contractors as compensation for consulting services, plus an additional 700,000 shares in a settlement agreement, totaling 11,370,000 shares. These are issued as restricted securities under Section 4(a)(2) of the Securities Act and Rule 506 of Regulation D, which is the classic structure for dilutive private placements. Item 3.02 is the designated disclosure item for unregistered equity sales, and the magnitude of shares issued represents material dilution to existing shareholders.
View raw filing on EDGAR →This Item 5.07 disclosure reports the final results of Avalon GloboCare's June 9, 2026 annual meeting of stockholders, including voting outcomes on six proposals: director elections, auditor ratification, stock incentive plan approval, say-on-pay advisory vote, warrant issuance approval, and reverse stock split authorization. The detailed vote tallies (For/Against/Abstain/Broker Non-Votes) for each proposal are the core content, making this a textbook shareholder_vote_results event. The warrant issuance and reverse split proposals are particularly material to investors assessing dilution and capital structure risk.
View raw filing on EDGAR →Bluejay Diagnostics held its Annual Meeting on June 9, 2026, and reported shareholder voting results on four proposals: director elections, authorization of a reverse stock split, approval of Amendment No. 1 to the 2021 Stock Plan (increasing share reserve by 600,000 shares), and ratification of Wolf & Company as independent auditor.
View raw filing on EDGAR →Nuvve held a special meeting of stockholders on June 9, 2026, which was adjourned due to lack of quorum (2,926,864 shares present fell short of the quorum requirement). The filing discloses the procedural outcome of the meeting adjournment and references Item 8.01 for additional details on the stockholder voting matter.
View raw filing on EDGAR →Jay Kim resigned as Co-Chief Executive Officer on June 4, 2026. Jung Jae Lim assumed full CEO responsibilities following Kim's departure.
View raw filing on EDGAR →Shareholders voted on June 3, 2026 to approve an extension of the Company's business combination deadline from June 6, 2026 to June 6, 2027, with up to twelve one-month extensions, along with related amendments to the Investment Management Trust Agreement.
View raw filing on EDGAR →The filing discloses the issuance of $458 million aggregate principal amount of 1.250% Convertible Senior Notes due 2032, with an additional $58 million issued upon full exercise of an option by initial purchasers. The Notes are convertible into common stock at an initial conversion price of approximately $7.41 per share (134.9073 shares per $1,000 principal). This is a material dilutive issuance of convertible debt securities that will result in equity dilution upon conversion. While technically a debt issuance under Item 1.01, the convertible feature and substantial principal amount make this a material capital-raising event with significant dilutive potential to existing shareholders.
View raw filing on EDGAR →This Item 1.01 discloses entry into a Second Amendment to a Merger Agreement dated June 4, 2026, which revises the definition of Fully Diluted Company Shares to include Open World ordinary shares issuable under existing equity agreements. The amendment modifies a material acquisition agreement's key financial terms, making it a material M&A activity event that would affect investor assessment of the transaction structure and valuation.
View raw filing on EDGAR →This 8-K Item 5.07 discloses the final voting results from Exagen Inc.'s 2026 annual meeting of stockholders held on June 9, 2026, covering three proposals: election of two Class I directors (Tina S. Nova and Scott Kahn), ratification of BDO USA, P.C. as independent auditor, and advisory approval of named executive officer compensation. The tabulated vote counts for each proposal are the core disclosure required by Item 5.07.
View raw filing on EDGAR →The disclosure announces two developments: (1) mobilization of field crews and commencement of the 2026 summer exploration program at the Upper Kobuk Mineral Projects (a material asset for a mineral exploration company), and (2) appointment of a new President at Ambler Metals LLC, the joint venture advancing the project. While the appointment of a new President at the joint venture could suggest exec_appointment, the filing does not clarify whether this person is a named executive of Trilogy itself or merely of the joint venture entity. The primary focus appears to be the operational milestone (field operations underway), which is material to investors in an exploration-stage company but does not fit neatly into the standard taxonomy categories. Classified as other_material given the ambiguity around the appointment's scope and the operational significance of the exploration program announcement.
View raw filing on EDGAR →Designer Brands Inc. issued a press release on June 9, 2026 announcing consolidated financial results for the quarter ended May 2, 2026, filed under Item 2.02 (Results of Operations and Financial Condition). The disclosure explicitly references a press release attached as Exhibit 99.1 containing quarterly financial results, which is the standard form of earnings release disclosure.
View raw filing on EDGAR →This is a classic Item 5.07 disclosure reporting the results of Palantir's June 3, 2026 annual meeting of stockholders. The filing details voting outcomes for six proposals: election of seven directors (all elected), ratification of Ernst & Young as independent auditor, advisory approval of named executive officer compensation, and three stockholder proposals (all rejected). The detailed vote tallies for each nominee and proposal are the core content of the disclosure.
View raw filing on EDGAR →This Item 2.03 disclosure describes the issuance of consolidated obligations (bonds and discount notes) by the Federal Home Loan Bank of Des Moines. While the filing creates a direct financial obligation under Item 2.03, the prose does not disclose a specific debt covenant breach, cross-default, or triggering event that accelerates financial obligations—the hallmarks of covenant_breach. Instead, it describes the routine issuance mechanism and regulatory framework for consolidated obligations. The materiality statement ("although consolidated obligations issuance is material to the Bank") indicates the event is material, but the specific event type does not fit cleanly into the more specific categories; it is best classified as other_material given the regulatory and structural nature of the disclosure.
View raw filing on EDGAR →This 8-K Item 2.03 discloses the issuance of a $250 million consolidated obligation bond (Variable Single Index Floater, maturing 09/04/2026, trade date 06/05/2026). While Item 2.03 is technically designed for covenant breaches and direct financial obligations, the FHLBank's disclosure here focuses on the creation of a debt obligation through consolidated bond issuance rather than a covenant breach or triggering event. This is material to investors as it represents a significant new debt obligation, but it does not fit cleanly into the more specific event categories (covenant_breach applies to triggering events that accelerate obligations, not routine debt issuance). The filing itself notes that "consolidated obligations issuance is material to the FHLBank," supporting materiality.
View raw filing on EDGAR →This Item 2.03 disclosure reports the issuance of consolidated obligations (bonds and discount notes) totaling approximately $285 million across multiple tranches with varying maturities, rates, and call features. While Item 2.03 is technically designed for covenant breaches and direct financial obligations, this filing uses it to disclose routine debt issuances by a Federal Home Loan Bank. The Bank explicitly states "consolidated obligations issuance is material to the Bank," and the disclosure is material to investors as it reflects significant new funding activity. However, this does not fit cleanly into the covenant_breach category (no breach is disclosed) and lacks the distress signals typical of that event type. The disclosure is a routine but material debt issuance by a regulated financial institution, best classified as other_material.
View raw filing on EDGAR →This Item 2.03 disclosure reports the creation of direct financial obligations through the issuance of consolidated obligations (bonds and discount notes) totaling approximately $216 million across seven separate issuances with maturities ranging from 2027 to 2031. While Item 2.03 typically signals covenant_breach or debt acceleration events, this filing discloses routine debt issuances in the ordinary course of business by a Federal Home Loan Bank, which is a specialized financial institution whose primary funding mechanism is consolidated obligation issuances. The disclosure is material to investors as it affects the Bank's capital structure and leverage, but does not fit the covenant_breach category (no triggering event or acceleration) and is better classified as other_material given the unique regulatory and operational context of FHLBank debt issuances.
View raw filing on EDGAR →This 8-K Item 2.03 discloses the creation of direct financial obligations through the issuance of consolidated obligations (bonds and discount notes) totaling approximately $1.325 billion across four separate issuances in early June 2026. While Item 2.03 is the designated section for debt obligations, the taxonomy lacks a specific "debt_issuance" category. The filing explicitly states "consolidated obligations issuance is material to the Bank," and these are material funding activities for a Federal Home Loan Bank. This is classified as "other_material" rather than "covenant_breach" (which addresses defaults) or "ma_activity" (which addresses acquisitions/dispositions).
View raw filing on EDGAR →This Item 2.03 disclosure reports the Federal Home Loan Bank of Indianapolis becoming the primary obligor on consolidated obligation bonds totaling approximately $773 million across multiple issuances with varying maturities (2027–2056) and rate structures. While Item 2.03 is technically a "direct financial obligation," the event does not fit cleanly into the covenant_breach category (no breach alleged) and the bonds are routine consolidated obligations issued by the FHLBank system rather than a discrete triggering event like a debt covenant violation. The disclosure is material to investors assessing the registrant's leverage and obligations, but the nature of the obligation—issuance of consolidated bonds—is a standard operational activity for a Federal Home Loan Bank rather than an exceptional material event.
View raw filing on EDGAR →This 8-K Item 2.03 discloses the creation of direct financial obligations through the issuance of consolidated obligation bonds totaling approximately $1.5 billion across seven bond issuances with varying maturities (3 months to 20 years) and rate structures. While Item 2.03 is the designated item for debt creation, the taxonomy lacks a specific "debt_issuance" category; the event is material to investors as it represents significant new borrowing by the Bank, but does not fit cleanly into covenant_breach (no breach disclosed) or other more specific categories. The disclosure is routine for an FHLBank's ordinary course funding operations, yet the magnitude and materiality warrant classification as a material event outside the standard taxonomy.
View raw filing on EDGAR →The filing discloses quarterly financial results for the period ended April 30, 2026 via a press release furnished as Exhibit 99.1. This is a classic earnings release disclosure under Item 2.02, which is material to investors as it provides the registrant's reported financial performance and is part of the total mix of information available about the company.
View raw filing on EDGAR →American Water Works disclosed two significant regulatory rate case settlements: a partial settlement agreement with the California Public Utilities Commission for Cal Am (subsidiary) involving $24–$43 million in incremental annualized revenue depending on CWIP treatment, and a stipulation of settlement with the Virginia State Corporation Commission for Virginia American Water involving a $16 million annualized revenue increase. These regulatory outcomes directly affect the company's future cash flows and profitability from its major operating subsidiaries. While not fitting neatly into the standard 8-K taxonomy (not M&A, not litigation, not impairment), the materiality of rate case outcomes to a regulated utility's financial performance and investor assessment warrants classification as a material event outside the more specific categories.
View raw filing on EDGAR →This is a classic Item 5.07 disclosure reporting the results of CervoMed's 2026 Annual Meeting of Stockholders held on June 8, 2026. The filing presents voting results for four proposals: election of eight directors, ratification of RSM US LLP as auditor, advisory approval of named executive officer compensation, and approval of an amendment to the 2025 Equity Incentive Plan. All proposals passed with the requisite majorities. This is a material disclosure as it documents shareholder approval of governance and compensation matters.
View raw filing on EDGAR →This is a clear auditor change under Item 4.01. Assure CPA, LLC resigned as the independent registered public accounting firm effective June 3, 2026, following its acquisition by Sadler Gibb & Associates, LLC. The Board appointed Sadler Gibb as the new independent registered public accounting firm on June 5, 2026. The filing explicitly confirms no disagreements, reportable events, or adverse audit opinions, indicating a routine transition rather than a dispute-driven change.
View raw filing on EDGAR →The filing discloses a press release announcing financial results for the fourth fiscal quarter and full fiscal year ended March 29, 2026, filed under Item 2.02 (Results of Operations and Financial Condition). This is a classic earnings release disclosure, which is material to investors as it provides the registrant's periodic financial performance.
View raw filing on EDGAR →The filing discloses a press release announcing financial results for the first quarter ended April 30, 2026, filed under Item 2.02 (Results of Operations and Financial Condition). This is a standard earnings release disclosure, which is material to investors as it provides periodic financial performance information.
View raw filing on EDGAR →Professional Diversity Network received written notification from Nasdaq on June 5, 2026, that it failed to comply with Nasdaq Listing Rule 5550(a)(2) due to its closing bid price falling below $1.00 per share for 30 consecutive business days. The company has been granted a 180-calendar day compliance period until December 2, 2026, to regain compliance, with potential delisting if it fails to do so. This is a classic delisting risk disclosure under Item 3.01.
View raw filing on EDGAR →On June 3, 2026, the Company entered into a Redemption Agreement to redeem and cancel all 1,153 outstanding shares of Series C Senior Convertible Preferred Stock for $922,400 in cash and termination of the underlying Equity Purchase Agreement. This material modification of the Company's equity structure eliminates a significant preferred equity position and was completed on June 8, 2026.
View raw filing on EDGAR →The Company amended its Articles of Incorporation to modify security holder rights, including the cancellation of Series AAA-2 and Series C preferred stock designations. While the cancellation of Series C relates to the redemption transaction, the broader modifications to security holder rights disclosed in Item 3.03 represent material changes to the Company's capitalization structure.
View raw filing on EDGAR →LiqTech entered into an Underwriting Agreement on June 4, 2026, for a registered public offering of 20,000,000 shares of common stock at $1.00 per share, with a 3,000,000 share over-allotment option. The offering closed on June 8, 2026, generating approximately $18.0 million in net proceeds for debt repayment and working capital.
View raw filing on EDGAR →LiqTech issued 3,000,000 shares of common stock on June 8, 2026, in a private placement exempt under Section 4(a)(2) and Rule 506(b), in exchange for cancellation of $3.0 million in senior promissory notes.
View raw filing on EDGAR →Skillsoft disclosed financial results for the fiscal quarter ended April 30, 2026 via a press release furnished as Exhibit 99.1 under Item 2.02.
View raw filing on EDGAR →